SCHEDULE: BioAge Labs Insider Boosts Stake to 7.2%

Kristen Fortney, a key insider at BioAge Labs, Inc., has increased her beneficial ownership to 7.2% of the company's common stock as of December 31, 2025.

Summary

• Kristen Fortney, the Reporting Person, beneficially owns an aggregate of 2,704,736 shares of BioAge Labs, Inc. Common Stock as of December 31, 2025.
• This ownership represents 7.2% of the Issuer's outstanding Common Stock.
• The total outstanding shares used for this calculation were 35,855,037 as of October 31, 2025, as reported in the Issuer's Form 10-Q for the period ended September 30, 2025.
• Dr. Fortney directly owns 1,210,056 shares of Common Stock.
• She also beneficially owns employee stock options to purchase an additional 1,459,187 shares of Common Stock, which were either vested or capable of vesting within 60 days of December 31, 2025.
• An additional 35,493 shares underlying employee stock options are directly beneficially owned by Dr. Fortney's spouse, Justin Rebo, over which he has voting rights.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development. An increase in beneficial ownership by a key insider like Kristen Fortney typically indicates strong internal confidence in the company's valuation and future performance, which is generally well-received by investors.

Positives

• Increased beneficial ownership by a key insider, Kristen Fortney, signals strong internal confidence in the company's future prospects.
• Dr. Fortney's aggregate beneficial ownership now stands at 7.2% of the outstanding common stock, demonstrating significant alignment with shareholder interests.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that increased insider ownership often signals management's confidence in the company's future prospects, aligning with long-term growth strategies. This move by a key individual like Kristen Fortney could be interpreted by the market as a positive indicator, especially in the biotech sector where long development cycles and regulatory hurdles are common.

Stakeholder Impact

• Shareholders may view the increased insider ownership as a positive signal, potentially boosting confidence in the company's leadership and future direction.
• The market might interpret this as a sign of strong alignment between management's interests and those of public shareholders.

Key Dates

Recommendation

The increase in beneficial ownership by a key insider, Kristen Fortney, suggests strong internal confidence in BioAge Labs, Inc.'s future. This insider accumulation is generally a positive signal for investors, indicating alignment between management and shareholder interests. However, without additional financial or operational updates, a 'hold' recommendation is prudent, encouraging investors to monitor further developments.

Keywords

BioAge Labs, Kristen Fortney, Insider Ownership, SEC Filing, Schedule 13G, Common Stock, Beneficial Ownership, Stock Options